SuperworthProgyny EPS PGNY
Diluted earnings per share by quarter and over the last twelve months, from 2018.
- Last 12 months, to Jun 30, 2026
- $0.92
- Latest quarter, Q2 FY26
- $0.34
- +79% on a year earlier
- Fiscal year 2025
- $0.65
- +14% on the year before
Progyny's earnings per share was $0.92 over the twelve months to Jun 30, 2026, up 56% on a year earlier.
In its latest quarter, Q2 FY26, it was $0.34, up 79% on the same quarter a year before.
Over the five fiscal years to FY2025 it grew 7% a year on average.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | $0.65 | +14% |
| FY2024 | $0.57 | −8% |
| FY2023 | $0.62 | +107% |
| FY2022 | $0.30 | −55% |
| FY2021 | $0.66 | +40% |
| FY2020 | $0.47 | n/a |
| FY2019 | −$0.87 | −8800% |
| FY2018 | $0.01 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | $0.34 | +79% | $0.92 | |
| Q1 FY26 | $0.29 | +71% | $0.77 | |
| Q4 FY25 | $0.14 | +17% | $0.65 | |
| Q3 FY25 | $0.15 | +36% | $0.63 | |
| Q2 FY25 | $0.19 | +12% | $0.59 | |
| Q1 FY25 | $0.17 | +0% | $0.57 | |
| Q4 FY24 | $0.12 | −8% | $0.57 | |
| Q3 FY24 | $0.11 | −31% | $0.58 | |
| Q2 FY24 | $0.17 | +13% | $0.63 | |
| Q1 FY24 | $0.17 | −6% | $0.61 | |
| Q4 FY23 | $0.13 | +333% | $0.62 | |
| Q3 FY23 | $0.16 | +23% | $0.52 |
Against its peers
Companies in Medical - Care Facilities nearest Progyny's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| PGNYProgyny | $0.92 | +56% a year |
| ADUSAddus HomeCare | $5.70 | +26% a year |
| MDPediatrix Medical | $2.09 | +62% a year |
| HCSGHealthcare Services | $1.72 | +176% a year |
| ARDTArdent Health | $0.55 | −70% a year |
| PRVAPrivia Health | $0.21 | +91% a year |
| AVAHAveanna Healthcare | $1.23 | +1267% a year |
| PNTGPennant | $0.90 | +15% a year |
| NHCNational Healthcare | $8.89 | +32% a year |
| USPHU S Physical Therapy | $0.88 | −63% a year |
| OMDAOmada Health | $0.06 | |
| Peer median | $1.06 |
Where Progyny ranks
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Progyny
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.